A detailed history of Balyasny Asset Management LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,303,945 shares of MOR stock, worth $23.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,303,945
Previous 31,602 4026.15%
Holding current value
$23.7 Million
Previous $312,000 7481.09%
% of portfolio
0.04%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$8.6 - $18.18 $10.9 Million - $23.1 Million
1,272,343 Added 4026.15%
1,303,945 $23.7 Million
Q4 2023

Feb 14, 2024

BUY
$4.55 - $9.9 $143,789 - $312,859
31,602 New
31,602 $312,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Market Cap $2.49B
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.